Stock 6821 ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Asymchem Laboratories (Tianjin) Co., Ltd. Hong Kong S.E.

Equities

6821

CNE100004Z06

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
63.35 HKD +7.37% Intraday chart for Asymchem Laboratories (Tianjin) Co., Ltd. +9.98% -30.38%
10:45am Nomura Adjusts Asymchem Laboratories’ Price Target to HK$83.94 From HK$90.12 Keeps at Buy MT
10:45am Nomura Adjusts Asymchem Laboratories’ Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy MT

Business Summary

Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is also engaged in the provision of pharmaceutical formulation solutions, biosynthetic solutions and clinical solutions.

Number of employees: 9,788

Sales per Business

CNY in Million2022Weight2023Weight Delta
Commercialization
65.3 %
7,587 74.0 % 5,112 65.3 % -32.61%
Clinical and Pre-clinical
19.3 %
1,666 16.2 % 1,507 19.3 % -9.56%
New Business
15.3 %
996 9.7 % 1,199 15.3 % +20.42%
Other
0.1 %
6 0.1 % 6 0.1 % +0.08%

Sales per region

CNY in Million2022Weight2023Weight Delta
Overseas
81.1 %
8,691 84.7 % 6,344 81.1 % -27.01%
China
18.9 %
1,564 15.3 % 1,481 18.9 % -5.31%

Managers

Managers TitleAgeSince
Rui Yang CEO
 Chief Executive Officer 47 99-03-31
Hao Hong CEO
 Chief Executive Officer 68 98-10-06
Elut Hsu PSD
 President - 96-12-31
Xinhui Hu CTO
 Chief Tech/Sci/R&D Officer 51 22-06-19
Da Zhang COO
 Chief Operating Officer 43 18-04-30
James Gage CTO
 Chief Tech/Sci/R&D Officer 60 11-07-17
Liang Hong BRD
 Director/Board Member 50 98-09-30
Chang Liang Yu IRC
 Investor Relations Contact 39 17-12-27
Xiaolian Huang PRN
 Corporate Officer/Principal 50 -
Ying Wei Jiang PRN
 Corporate Officer/Principal 49 19-12-31

Members of the board

Members of the board TitleAgeSince
Hao Hong CEO
 Chief Executive Officer 68 98-10-06
Kar Chung Lee BRD
 Director/Board Member 43 21-06-15
Ye Song BRD
 Director/Board Member 63 11-07-17
Liang Hong BRD
 Director/Board Member 50 98-09-30
Xin Xin Zhi CHM
 Chairman 44 03-06-30
Ting Zhang BRD
 Director/Board Member 38 14-12-04
Shan Shan Di BRD
 Director/Board Member 38 17-10-30
Da Zhang COO
 Chief Operating Officer 43 18-04-30
Jing Yi Hou BRD
 Director/Board Member 41 06-12-31
Xue Jiao Sun BRD
 Director/Board Member - 23-10-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,553,260 27,553,260 ( 100.00 %) 0 60.56 %
Stock B 1 348,840,365 200,382,332 ( 57.44 %) 6,922,092 ( 1.984 %)

Shareholders

NameEquities%Valuation
JPMorgan Asset Management (Asia Pacific) Ltd.
16.71 %
4,605,180 16.71 % 36 M $
HHLR Advisors Ltd.
14.33 %
3,948,000 14.33 % 31 M $
Schroder Investment Management (Hong Kong) Ltd.
11.34 %
3,125,900 11.34 % 25 M $
Norges Bank Investment Management
5.684 %
1,566,200 5.684 % 12 M $
Springhill Fund Asset Management (HK) Co. Ltd.
4.940 %
1,361,060 4.940 % 11 M $
Fidelity Management & Research (Hong Kong) Ltd.
4.468 %
1,231,140 4.468 % 10 M $
ICBC Credit Suisse Asset Management Co., Ltd.
2.266 %
624,320 2.266 % 5 M $
Fidelity Management & Research Co. LLC
1.855 %
511,074 1.855 % 4 M $
Huashang Fund Management Co., Ltd.
1.514 %
417,200 1.514 % 3 M $
JPMorgan Asset Management (Taiwan) Ltd.
1.328 %
365,860 1.328 % 3 M $
NameEquities%Valuation
Asymchem Laboratories, Inc.
35.15 %
115,133,168 35.15 % 1 371 M $
Zhong Ou Asset Management Co., Ltd
6.808 %
22,301,570 6.808 % 265 M $
Hwabao WP Fund Management Co., Ltd.
2.036 %
6,670,506 2.036 % 79 M $
Tianjin Guorong Business Information Consulting Co. Ltd.
2.001 %
6,555,504 2.001 % 78 M $
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
1.352 %
4,429,800 1.352 % 53 M $
China Merchants Fund Management Co., Ltd.
1.326 %
4,344,553 1.326 % 52 M $
Hao Hong
1.089 %
3,567,175 1.089 % 42 M $
Huashang Fund Management Co., Ltd.
0.9356 %
3,064,682 0.9356 % 36 M $
ICBC Credit Suisse Asset Management Co., Ltd.
0.8081 %
2,647,008 0.8081 % 32 M $
Yinhua Fund Management Co., Ltd.
0.5857 %
1,918,655 0.5857 % 23 M $
NameEquities%Valuation
Hao Hong
72.27 %
10,701,524 72.27 % 127 M $
Yi Xiao
1.276 %
189,000 1.276 % 2 M $
Ying Wei Jiang
1.276 %
189,000 1.276 % 2 M $
Da Zhang
1.276 %
189,000 1.276 % 2 M $
Xiang Ke Xu
0.5815 %
86,100 0.5815 % 1 M $
Yan Zhou
0.4791 %
70,942 0.4791 % 844 537 $
Xiao Lian Huang
0.4771 %
70,638 0.4771 % 840 918 $
Chao Yong Chen
0.4575 %
67,741 0.4575 % 806 430 $

Holdings

NameEquities%Valuation
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
1.35%
 4,429,800 1.35% 52,735,041 $

Company contact information

Asymchem Laboratories (Tianjin) Co., Ltd.

71 7th Street Tianjin Economic & Tech Dev Zone

300457, Tianjin

+

http://www.asymchem.com.cn
address Asymchem Laboratories (Tianjin) Co., Ltd.(6821)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Asymchem Laboratories (Tianjin) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
76.86 CNY
Average target price
112.1 CNY
Spread / Average Target
+45.91%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.47% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.13% 233B
NOVARTIS AG Stock Novartis AG
+5.18% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.14% 193B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 143B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002821 Stock
  4. 6821 Stock
  5. Company Asymchem Laboratories (Tianjin) Co., Ltd.